Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection

NCT00911963 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: VCH-222 or matching placebo
DRUG: VCH-222 or matching placebo
BIOLOGICAL: peginterferon alfa-2a
DRUG: ribavirin

Sponsor

Vertex Pharmaceuticals Incorporated

Collaborators

[object Object]